# Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-phase-ii-trial-of-carboplatin-paclitaxel-versus-carboplatin/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Amanda N. Fader,Dana M. Roque,Eric R. Siegel,Natália Buza,Pei Hui,Osama Abdelghany,Setsuko K. Chambers,Angeles Alvarez Secord,Laura J. Havrilesky,David M. O’Malley,Floor Backes,Nicole Nevadunsky,Babak Edraki,Dirk Pikaart,William J. Lowery,Karim ElSahwi,Paul Celano,Stefania Bellone,Masoud Azodi,Babak Litkouhi,Elena Ratner,Dan‐Arin Silasi,Peter E. Schwartz,Alessandro D. Santin |
| Citations | 534 |
| DOI | 10.1200/jco.2017.76.5966 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://repository.arizona.edu/bitstream/10150/631014/1/jco.2017.76.5966.pdf |
| OpenAlex ID | https://openalex.org/W2794839527 |
| PMID | 29584549 |
| Type | article |
| Year | 2018 |

## Paper authors

- [David M. O’Malley](https://scholariq.org/researchers/david-m-o-malley/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.